Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,325
Closed -$56K 2343
2024
Q2
$56K Buy
+10,325
New +$58K ﹤0.01% 1820
2023
Q3
Sell
-1,538
Closed -$9K 2332
2023
Q2
$9K Buy
+1,538
New +$12.3K ﹤0.01% 2178
2022
Q3
Sell
-10,983
Closed -$304K 2723
2022
Q2
$304K Buy
10,983
+4,146
+61% +$142K ﹤0.01% 2011
2022
Q1
$298K Buy
6,837
+5,200
+318% +$226K ﹤0.01% 2236
2021
Q4
$90K Buy
+1,637
New +$101K ﹤0.01% 2780
2018
Q2
Sell
-1,504
Closed -$27K 267
2018
Q1
$27K Buy
+1,504
New +$28.4K 0.01% 194

Other funds holding AFMD

HRT Financial's AFMD Position: Q3 2024 in Review

HRT Financial sold out of Affimed (AFMD) in Q3 2024, closing a stake of 10,325 shares — an estimated $56K sold.

HRT Financial first reported a position in AFMD in Q1 2018 and held it in 6 quarters. The position peaked at $304K in Q2 2022. 40 funds tracked by Wall St. Rank hold AFMD as of Q3 2024.

  • HRT Financial reported no remaining Affimed position as of Q3 2024 after selling out during the quarter.
  • HRT Financial sold 10,325 Affimed shares in Q3 2024, an estimated $56K.
  • HRT Financial first reported a position in Affimed in Q1 2018 and held it in 6 quarters.
  • HRT Financial's Affimed position peaked at $304K in Q2 2022.
  • 40 funds tracked by Wall St. Rank held Affimed as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.